Age-related macular degeneration : antioxidants and zinc might slow down the disease
Published the 28.08.2017 at 08: 20am
Macular degeneration age-related (AMD) is the leading cause of visual disability in people older than 50 years, reminds us of the Inserm. She even touches up to 30% of the over 75 years of age, and the incidence of the disease is expected to continue to increase in the years to come.
One of the forms of the disease, known as ” wet “, benefits of treatment : inhibitors of VEGF. The treatment often slows down its evolution, but require injections at regular intervals, performed in the ophthalmologist, and they are expensive.
To improve the treatment, supplementation with antioxidants and zinc would be an effective solution, and would make substantial savings, according to a study, us-uk, published in the British Journal of ophtalmology.
To arrive at these conclusions, researchers relied on data from the study AREDS (Age-related eye disease study), and on the numbers british of expenses related to the AMD.
According to the AREDS trial, a combination of vitamins C and E, beta-carotene, zinc and copper, or the same cocktail without beta-carotene replaced by lutein and zeaxanthin, is effective to slow the progression of the disease. It would increase the shelf life without loss of vision.
These additions are already available in the trade.